DCVax-Prostate
/ Northwest Biotherap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 10, 2014
Northwest Biotherapeutics: Rodman & Renshaw Global Investments Conference
(Northwest Biotherapeutics)
- "Completed multi-center Phase I / II trial with 36 patients"; "Showed positive efficacy signal and good safety (no toxicity)";
P1/2 data • Oncology • Prostate Cancer
1 to 1
Of
1
Go to page
1